Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine Versus S-1 in Elderly Patients With Advanced Gastric Cancer
NCT00278863Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2004
- Primary completion
- Jan 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in gastric cancer (GC) comparing S-1 with Capecitabine (2 arms). Primary endpoint: Response Rate at 2 years. Started Nov 2004; status: completed.
02
Drugs
capecitabinetegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00278863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278863.